Impiricus Ranks No. 14 on the 2026 Inc. 5000

FCA Venture Partners is proud to celebrate FCA Health Innovations II portfolio company Impiricus being named No. 14 on the 2026 Inc. 5000, recognizing it as one of the fastest-growing private companies in the United States.

Impiricus reported nearly 12,000% growth over the past three years - an achievement the company recently celebrated by ringing the Nasdaq Opening Bell. This milestone reflects the company’s strong execution and the growing demand for more effective, physician-centered approaches to healthcare commercialization.

Impiricus began by building a trusted platform that enables life sciences organizations to engage physicians on their terms. Today, the company is developing an agentic AI-powered commercialization platform designed to identify physician needs and connect healthcare professionals with relevant clinical resources, patient-support services, and field teams in real time. Its broader mission is to turn physician engagement into action and help patients access treatment more quickly.

Read the press release here and the Company's announcement on LinkedIn here.